SYMBIOSIS LLC
SYMBIOSIS LLC
Status:
Active
Similar Organizations
Logos Capital
Logos Capital is a fundamental biotechnology-focused investment fund.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-05 | SalioGen Therapeutics | SymBiosis LLC investment in Series B - SalioGen Therapeutics | 115 M USD |
| 2021-11-04 | Platelet BioGenesis | SymBiosis LLC investment in Series B - Platelet BioGenesis | 75.5 M USD |
| 2021-07-21 | Vedanta Biosciences | SymBiosis LLC investment in Series D - Vedanta Biosciences | 43 M USD |
| 2021-03-02 | EGenesis | SymBiosis LLC investment in Series C - EGenesis | 125 M USD |
| 2021-03-01 | Carisma Therapeutics | SymBiosis LLC investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-02-17 | Micronoma | SymBiosis LLC investment in Convertible Note - Micronoma | 3.5 M USD |
| 2021-02-11 | Ensoma | SymBiosis LLC investment in Series A - Ensoma | 70 M USD |
| 2021-01-07 | Carisma Therapeutics | SymBiosis LLC investment in Series B - Carisma Therapeutics | 47 M USD |
| 2020-12-30 | Clene Nanomedicine | SymBiosis LLC investment in Post-IPO Equity - Clene Nanomedicine | 22.4 M USD |
| 2020-09-22 | Siolta Therapeutics | SymBiosis LLC investment in Series B - Siolta Therapeutics | 30 M USD |